Additional Listing

3 Mar 2006 16:03

Akers Biosciences, Inc.03 March 2006 Akers Biosciences, Inc. ("the Company") Issue of Equity On 28 February 2006, Akers Biosciences, Inc. announced the successful completionof the acquisition of the assets of WNCK, Inc. ("WNCK") of the Woodlands, Texas,USA. Included in the consideration for the transaction, and as was noted in theaforementioned announcement, was 125,000 shares of the company's stock. Application has now been made to the London Stock Exchange for the 125,000Common Shares to be admitted to trading, such admission expected to take placeon 8 March 2006. Contact:Paul B. Freedman - 001 856 848 2116 End This information is provided by RNS The company news service from the London Stock Exchange